Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

Video

» Interview

Beyond the Data: Digesting the 2024 ESC CCS Guidelines

December 16, 2024

Video

» Interview

Ultralow-Contrast PCI: Why, What, and How?

December 12, 2024

Video

» Interview

Beyond the Data: Catching Up on CITIC 2023

July 18, 2023

Video

» Interview

Beyond the Data: DEFINE-FLAIR at 5 Years

June 5, 2023

Video

» Interview

Beyond the Data: RENOVATE-COMPLEX-PCI: Optimizing Complex Procedures

March 5, 2023

Video

» Interview

Beyond the Data: Defining Complex PCI

September 17, 2022

Video

» Interview

FAME 3 Substudies: Clinical Outcomes Related to Anatomic vs. Functional Significance and Prognostic Value of Post-PCI FFR

September 17, 2022

Video

» Interview

Beyond the Data: Abbreviated DAPT After Complex PCI in High-Bleeding-Risk Patients

May 18, 2022

Video

» Interview

Beyond the Data: ACS/PCI Updates

April 3, 2022

Video

» Interview

OPTIMUM: PCI for Patients Not Suitable for CABG

November 7, 2021

Video

» Interview

OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

November 5, 2021

Video

» Interview

TALOS-AMI: Clopidogrel vs Ticagrelor in Stabilized Patients After PCI for Acute MI

June 11, 2021

Video

» Interview

Sex-Specific Outcomes in TWILIGHT: Ticagrelor With or Without Aspirin After PCI

May 24, 2021

Video

» Interview

HOST-EXAM: Aspirin vs Clopidogrel During Chronic Maintenance Monotherapy After PCI

May 20, 2021

Video

» Interview

TARGET FFR: A Randomized Trial of Physiology-Guided PCI Optimization

October 16, 2020

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Gregg W. Stone About EXCEL: 5-Year Outcomes From a Randomized Trial of PCI vs. CABG in Patients With Left Main Coronary Artery Disease

September 29, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Usman Baber About the TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

September 28, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Myeong-Ki Hong About IVUS-XPL: 5-Year Outcomes From a Randomized Trial of Intravascular Ultrasound-Guided vs. Angiography-Guided PCI of Long Coronary Lesions

September 28, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. David Wood About the COMPLETE Timing Substudy: A Randomized Trial of Complete Staged Revascularization vs. Infarct Artery PCI Alone in Patients With Acute Myocardial Infarction and Multivessel Disease

September 28, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Roxana Mehran About TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

September 27, 2019

Advertisement

Beyond the Data: Digesting the 2024 ESC CCS Guidelines

Ultralow-Contrast PCI: Why, What, and How?

Beyond the Data: Catching Up on CITIC 2023

Beyond the Data: DEFINE-FLAIR at 5 Years

Beyond the Data: RENOVATE-COMPLEX-PCI: Optimizing Complex Procedures

Beyond the Data: Defining Complex PCI

FAME 3 Substudies: Clinical Outcomes Related to Anatomic vs. Functional Significance and Prognostic Value of Post-PCI FFR

Beyond the Data: Abbreviated DAPT After Complex PCI in High-Bleeding-Risk Patients

Beyond the Data: ACS/PCI Updates

OPTIMUM: PCI for Patients Not Suitable for CABG

OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

TALOS-AMI: Clopidogrel vs Ticagrelor in Stabilized Patients After PCI for Acute MI

Sex-Specific Outcomes in TWILIGHT: Ticagrelor With or Without Aspirin After PCI

HOST-EXAM: Aspirin vs Clopidogrel During Chronic Maintenance Monotherapy After PCI

TARGET FFR: A Randomized Trial of Physiology-Guided PCI Optimization

Dr. C. Michael Gibson Talks With Dr. Gregg W. Stone About EXCEL: 5-Year Outcomes From a Randomized Trial of PCI vs. CABG in Patients With Left Main Coronary Artery Disease

Dr. C. Michael Gibson Talks With Dr. Usman Baber About the TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Dr. C. Michael Gibson Talks With Dr. Myeong-Ki Hong About IVUS-XPL: 5-Year Outcomes From a Randomized Trial of Intravascular Ultrasound-Guided vs. Angiography-Guided PCI of Long Coronary Lesions

Dr. C. Michael Gibson Talks With Dr. David Wood About the COMPLETE Timing Substudy: A Randomized Trial of Complete Staged Revascularization vs. Infarct Artery PCI Alone in Patients With Acute Myocardial Infarction and Multivessel Disease

Dr. C. Michael Gibson Talks With Dr. Roxana Mehran About TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content